Tine to Change Logo

The company’s shares are only traded on the London Stock Exchange’s AIM market at present.

The Company has one class of share in issue, being ordinary shares with a nominal value of 10p each. As at 25 June 2019 there were 182,186,111 shares in issue.

There are no shares held in Treasury.

There are no restrictions on the transfer of securities.

The percentage of shares not in public hands is 25.65%.


Major Shareholders above 3%:

Updated as at 27th November 2020.

Name Number
of shares
% of total
Richard Sneller 18,761,500 10.3%
Stonehage Fleming Investment Management Ltd 18,390,000 10.09%
Miton Asset Management Limited 17,639,123 9.68%
Columbia Threadneedle Investments 11,532,834 6.33%
Harwood Capital LLP 10,380,000 5.7%
David & Monique Newlands 10,075,000 5.53%
Liontrust Investment Partners LLP 8,136,423 4.47%
Unicorn Asset Management Limited 5,759,291 3.16%

Directors’ shareholdings:

Name Number
of shares
% of total
Mr Robert Holt OBE (Chairman) 1,299,810 0.71%
Mr Mike Rogers, Non-Executive Director 190,000 0.1%
Mr Tony Bourne, Non-Executive Director 161,000 0.09%
Mrs Wendy Lawrence, Chief Executive Officer 133,123 0.07%
Mrs Lisa Barter, Finance Director 133,000 0.07%
Mrs Gloria Cooke, Clinical Quality Director 50,500 0.03%

For all shareholder enquiries please contact John Charlton, Group Company Secretary at